TIFFANY L JOCO

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Acute Care MANSFIELD, TX NPI 1780153775

General Payments — all program years on this page

$1,989.75

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 78
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $737.81 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $737.8121

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $304.9225
2022 $482.5717
2023 $464.4515
2024 $737.8121

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086997370 Novartis Pharmaceuticals Corporation $15.88 02/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086997380 Novartis Pharmaceuticals Corporation $14.54 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086997382 Novartis Pharmaceuticals Corporation $17.29 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086997384 Novartis Pharmaceuticals Corporation $14.86 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086997386 Novartis Pharmaceuticals Corporation $17.09 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086997390 Novartis Pharmaceuticals Corporation $16.42 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086997442 Novartis Pharmaceuticals Corporation $15.07 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1092609932 Boston Scientific Corporation $23.53 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104708157 AstraZeneca Pharmaceuticals LP $17.30 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105477477 AstraZeneca Pharmaceuticals LP $19.61 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116991322 Medtronic, Inc. $137.66 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117288013 Amgen Inc. $21.65 01/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117288015 Amgen Inc. $24.24 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117288017 Amgen Inc. $16.78 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117288019 Amgen Inc. $18.11 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117288021 Amgen Inc. $18.18 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117288023 Amgen Inc. $21.00 09/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141686347 Merck Sharp & Dohme LLC $121.79 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151832952 Chiesi USA, Inc. $25.37 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153012393 ShockWave Medical, Inc $103.99 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153013291 ShockWave Medical, Inc $57.45 09/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.